US Pharma MarketingThe post NHS to offer precision prostate cancer treatment, cutting radiotherapy doses required appeared first on Medical Device Network.
NHS to offer precision prostate cancer treatment, cutting radiotherapy doses required
Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with conventional radiotherapy. Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with conventional radiotherapy. SABR’s roll-out across NHS England is being made possible following the UK Labour Government’s investment in new linear accelerator machines that deliver the therapy, coming as part of the NHS and government’s ‘National Cancer Plan for England’. Credit: Marbury / Shutterstock.com NHS England is set to offer thousands of men with prostate cancer a form of targeted radiation therapy for the first…
Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with conventional radiotherapy.
Source: Medical Device Network